By ISRAEL21c —— Bio and Archives--December 14, 2016
Tiny “barcodes” made of synthetic DNA can help determine the suitability of specific anticancer drugs to a specific patient before treatment even begins, according to an Israeli study recently published in Nature Communications.
The new diagnostic technology was developed by Technion-Israel Institute of Technology researchers led by Assistant Prof. Avi Schroeder of the Faculty of Chemical Engineering and the Technion Integrated Cancer Center.
“The medical world is now moving towards personalized medicine, but treatments tailored only according to the patient’s genetic characteristics don’t always grant an accurate prediction of which medicine will be best for each patient,” explained Schroeder. “We, however, have developed a technology that complements this field.” --More...The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy
Support Canada Free Press
